Week in Review: IL ups MMJ program, more CannTrust woes, NM studies legalizing adult-use cannabis & more

Illinois adds more qualifying medical cannabis conditions, CannTrust hit with second noncompliance notice for another facility, New Mexico panel studies the potential to legalize recreational marijuana in the state – and more of the week’s top cannabis business news.

What’s behind the stock correction in cannabis?

This has been a roller-coaster year for cannabis stocks, a signal that investors are assessing the opportunity more critically than they have before.

Arcview deal: Does more investor interest mean more scrutiny?

The latest investment news from The Arcview Group could indicate greater institutional investor interest in the cannabis sector, but it could also signal higher expectations and more rigorous scrutiny from investors.

Early Cannabis Investors Poised to Reap Massive Rewards of Growing Institutional Interest

As support for federal U.S. cannabis reform continues to build, institutional investors are taking notice – and once they make the leap, investors already in the space are well positioned to reap the rewards.

Weekly Wrapup: Beyond the headlines for the week ended July 12, 2019

Here’s a recap of the top newsmakers and deals that caught our eyes here at Investor Intelligence this week.

Number of Note: $1 Billion

This is the revenue target for a number of larger U.S. and Canadian cannabis companies over the next few years – and for some, they’re projecting it for as early as next year.

Curaleaf’s $1B buy, cannabis brews, social use progress & more of the week’s top news

Curaleaf is buying Cura Partners for close to $1 billion, Canada’s largest independent brewery takes the cannabis plunge, Colorado and Las Vegas join the social use bandwagon – plus other important news from around the marijuana industry.